Aoo.Br

AOO.BR's capital structure is characterized by a debt-to-equity ratio of 0.7, indicating a moderate level of leverage. The company's liquidity position is constrained, as evidenced by a current ratio of 0.22 and zero cash and equivalents, which suggests a reliance on operating cash flow to meet short-term obligations.

Profitability metrics show a return on equity (ROE) of 6.67% and a return on assets (ROA) of 3.77%. These figures are below the industry median for healthcare REITs, suggesting that AOO.BR is underperforming in terms of asset utilization and equity returns.

Geographically, AOO.BR's revenue is concentrated in the healthcare real estate segment, with no disclosed diversification into other property types or regions. This concentration increases exposure to sector-specific risks, such as regulatory changes or shifts in healthcare demand.

The company's growth trajectory is modest, with a free cash flow of -35.48 million EUR and a capital expenditure of -97.46 million EUR. These figures indicate that AOO.BR is investing in its operations but is not generating sufficient cash to cover these investments, which may impact long-term growth.

Risk factors include a medium liquidity risk due to the lack of cash reserves and a negative net cash position after subtracting total debt. The dilution risk is low, as there is no indication of imminent share issuance or dilution events. However, the company's reliance on operating cash flow to service debt and fund operations introduces credit risk.

Recent events include analyst estimates indicating a mean price target of 80.86 EUR and a median price target of 81.50 EUR. The mean recommendation of 1.79 suggests a generally positive outlook from analysts, with 5 strong-buy and 7 buy ratings.